The V2R Group Portfolio Companies
V2R Group has a diversified portfolio of technology companies, essentially business pillars that serve as the foundation of our diversification strategy. The combination of these business pillars, under the umbrella of V2R Group's strategic leadership and infrastructure, form the bedrock of our unique offering.
Under the leadership of our technology industry veterans, V2R Group is engaged with multiple cutting edge technology based companies, with an initial focus on Healthcare Diagnostics and Devices (one of the fastest growing markets in today's high tech economy) and technology-based productivity enhancements. Having led research and technology deployment and commercialization programs in private sector, university, and US federal laboratories for many years, our management team's background and experience provide V2R Group with unique access to high tech research and spin-off companies from the private and public sectors.
We enjoy an excellent "early look" relationship with a number of universities wherein select research has been sponsored by federal agencies to the prototype or early development stages. Technologies or companies under consideration for acquisition by V2R Group have typically been supported by millions of US federal agency dollars already invested in cutting edge research and development, greatly reducing the opportunity's early stage R&D risk for V2R Group. Our management team leverages our technology commercialization and business expertise to minimize go-to-market costs, and enhance the chances of successful market penetration. In essence, V2R Group drives the portfolio company's vision to market reality; with the early R&D risks and costs already assumed by our university and government agency partners, providing V2R Group with the greatest chances for successful market penetration by leveraging our business and technology commercialization skills.